MemorialCare joins innovative effort to solve nation’s drug shortage

MemorialCare, a national leader in value-based care, is partnering with Civica Rx, the not-for-profit collaborative generic drug company, to drive down costs and increase supplies of life-saving medicines. MemorialCare includes Long Beach Medical Center, Miller Children’s & Women’s Hospital Long Beach, MemorialCare Medical Group as well as medical imaging, ambulatory surgery, urgent care, dialysis and physicians practices throughout the Greater Long Beach area, Northern (Orange Coast Medical Center, Fountain Valley and Southern Orange County (Saddleback Medical Center).

MemorialCare joins other prominent health systems, including Mayo Clinic, to sign on with Civica. More than 900 U.S. hospitals and health systems have joined the venture, with many more expressing interest. Through a collaborative approach, the partnership is identifying production needs of in-demand drugs and developing high-quality FDA-approved medications at affordable prices within a robust supply chain.

“Civica’s new, highly-collaborative approach is needed to solve America’s drug shortage crisis,” says Barry Arbuckle, PhD, MemorialCare President & CEO. “MemorialCare’s long-time national leadership in delivering high-quality, accessible care and superb patient experience at a reduced cost has resulted in remarkable outcomes and benefits to local communities.”

MemorialCare continues to revolutionize healthcare with rapid movement to convenient, less costly and high-quality outpatient centers. The nonprofit health system offers more than 200 sites of care, in addition to four hospitals in Los Angeles and Orange counties. MemorialCare is uniquely positioned to provide consumers, employers and health plans high value healthcare in the right location, with the right services and at the right price, which aligns with the critically important mission of Civica.

“We are thrilled to welcome highly-regarded health systems like MemorialCare to Civica,” says Martin VanTrieste, President and CEO of Civica Rx. “Drug shortages have become a national crisis in which patient treatments and surgeries are canceled, delayed or suboptimal. We thank MemorialCare for joining us to make essential generic medicines accessible and affordable in hospitals across the country.”

Civica expects to bring 14 hospital-administered generic drugs to hospitals and healthcare systems in 2019 as the company’s initial efforts, with many additional medications prioritized by the healthcare systems as the next phase of focus.

This article was released by MemorialCare.